Xarelto


FDA Panel Once Again Rejects New Indication For J&J Drug

FDA Panel Once Again Rejects New Indication For J&J Drug

The FDA’s Cardiovascular and Renal Drugs Advisory Committee once again turned down the supplemental new drug application for an...

Jan 16 2014, 5:36pm CST

Johnson & Johnson Faces Uphill Battle At FDA Advisory Panel

Johnson & Johnson Faces Uphill Battle At FDA Advisory Panel

The third time may not be the charm. Twice before the FDA has turned down the supplemental new drug application for an acute co...

Jan 14 2014, 2:16pm CST

Pfizer's Expiring Viagra Patent Adversely Affects Other Drugmakers Too

Pfizer's Expiring Viagra Patent Adversely Affects Other Drugmakers Too

By David J. Phillips Looking ahead, the sex business isn’t expected to be as profitable as it once was for Pfizer Eli Lilly (LL...

Dec 20 2013, 11:26am CST